BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 17204584)

  • 1. Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection.
    Witte I; Plappert U; de Wall H; Hartmann A
    Toxicol Sci; 2007 May; 97(1):21-6. PubMed ID: 17204584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic toxicity assessment: employing the best science for human safety evaluation. Part I: Early screening for potential human mutagens.
    Jacobson-Kram D; Contrera JF
    Toxicol Sci; 2007 Mar; 96(1):16-20. PubMed ID: 17194803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic toxicity assessment: employing the best science for human safety evaluation part IV: Recommendation of a working group of the Gesellschaft fuer Umwelt-Mutationsforschung (GUM) for a simple and straightforward approach to genotoxicity testing.
    Pfuhler S; Albertini S; Fautz R; Herbold B; Madle S; Utesch D; Poth A;
    Toxicol Sci; 2007 Jun; 97(2):237-40. PubMed ID: 17303579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
    Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
    Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing.
    Rothfuss A; Honma M; Czich A; Aardema MJ; Burlinson B; Galloway S; Hamada S; Kirkland D; Heflich RH; Howe J; Nakajima M; O'Donovan M; Plappert-Helbig U; Priestley C; Recio L; Schuler M; Uno Y; Martus HJ
    Mutat Res; 2011 Aug; 723(2):108-20. PubMed ID: 21182982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxicity of environmental agents assessed by the alkaline comet assay.
    Møller P
    Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic toxicity assessment: employing the best science for human safety evaluation Part VII: Why not start with a single test: a transformational alternative to genotoxicity hazard and risk assessment.
    Ku WW; Aubrecht J; Mauthe RJ; Schiestl RH; Fornace AJ
    Toxicol Sci; 2007 Sep; 99(1):20-5. PubMed ID: 17548889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of genotoxicity test procedures with Episkin, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds?
    Flamand N; Marrot L; Belaidi JP; Bourouf L; Dourille E; Feltes M; Meunier JR
    Mutat Res; 2006 Jul; 606(1-2):39-51. PubMed ID: 16675293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo.
    Kirkland D; Speit G
    Mutat Res; 2008 Jul; 654(2):114-32. PubMed ID: 18585956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vivo comet assay: use and status in genotoxicity testing.
    Brendler-Schwaab S; Hartmann A; Pfuhler S; Speit G
    Mutagenesis; 2005 Jul; 20(4):245-54. PubMed ID: 15899933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay.
    Hastwell PW; Chai LL; Roberts KJ; Webster TW; Harvey JS; Rees RW; Walmsley RM
    Mutat Res; 2006 Sep; 607(2):160-75. PubMed ID: 16781187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comet assay as an indicator test for germ cell genotoxicity.
    Speit G; Vasquez M; Hartmann A
    Mutat Res; 2009; 681(1):3-12. PubMed ID: 18462987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of RAD51C, Cystatin A, p53 and Nrf2 luciferase-reporter assays in metabolically competent HepG2 cells for the assessment of mechanism-based genotoxicity and of oxidative stress in the early research phase of drug development.
    Westerink WM; Stevenson JC; Horbach GJ; Schoonen WG
    Mutat Res; 2010 Feb; 696(1):21-40. PubMed ID: 20006733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico studies with human DNA topoisomerase-II alpha to unravel the mechanism of in vitro genotoxicity of benzene and its metabolites.
    Pandey AK; Gurbani D; Bajpayee M; Parmar D; Ajmani S; Dhawan A
    Mutat Res; 2009 Feb; 661(1-2):57-70. PubMed ID: 19059273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis and predictive value of the rodent in vivo micronucleus assay results.
    Benigni R; Bossa C; Worth A
    Mutagenesis; 2010 Jul; 25(4):335-41. PubMed ID: 20194420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.